SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

Abstract
Mutations in components of the BAF (mammalian SWI/SNF) complex promoted thyroid cancer, reduced expression of thyroid differentiation genes, blocked the redifferentiation effects of MAPK inhibition, and reduced radioiodine treatment efficacy in vivo.
Funding Information
  • NIH (CA50706-23)
  • NIH (CA184724-01A1)
  • NIH (DK-15070)
  • NCI (P50 CA 172012-01)
  • Translational Research Oncology Training program (5T32CA160001)
  • NCI (P30 CA08748)